Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Black Diamond Therapeutics (BDTX) Operating Margin (2025)

Black Diamond Therapeutics' Operating Margin history spans 1 years, with the latest figure at 77.9% for Q1 2025.

  • For Q1 2025, Operating Margin changed N/A year-over-year to 77.9%; the TTM value through Dec 2025 reached 17.89%, changed N/A, while the annual FY2025 figure was 17.89%, N/A changed from the prior year.
  • Operating Margin reached 77.9% in Q1 2025 per BDTX's latest filing.
  • In the past five years, Operating Margin ranged from a high of 77.9% in Q1 2025 to a low of 77.9% in Q1 2025.